Literature DB >> 18242732

Coronary collaterals improve prognosis in patients with ischemic heart disease.

Jakub J Regieli1, J Wouter Jukema, Hendrik M Nathoe, Aeilko H Zwinderman, Sunanto Ng, Diederick E Grobbee, Yolanda van der Graaf, Pieter A Doevendans.   

Abstract

BACKGROUND: The recruitment of coronary collateral vessels results from an endogenous adaptation to ischemic heart disease (IHD). Presence of collaterals may exert protection at the time of acute or chronic obstructive coronary disease. The protective role of collaterals in patients with extensive coronary artery disease however, has been disputed. We examined the effects of coronary collateral circulation on cardiovascular outcomes, with an emphasis on clinical prognostic value and on a putative role of IHD burden.
METHODS: Data analyzed were obtained in the REGRESS study, involving 879 male participants undergoing coronary angiography and being followed for 24 months. Presence of coronary collaterals spontaneously visible on angiography was assessed. Events included: myocardial infarction (MI), coronary heart disease death and percutaneous or surgical coronary intervention. Estimates of relative risks of outcome events were calculated using proportional hazard analysis, with adjustments for confounding factors and stratification for initial revascularization strategy and factors reflecting extent of IHD burden.
RESULTS: Event-free survival after two years was 84% in patients without collaterals, and 92% in patients with collaterals (p=0.0020). The crude HR was 0.48 (95% CI: 0.30-0.77), and 0.38 (0.23-0.65) after adjustment for confounders and cardiovascular risk factors. The protective effect of coronary collaterals was not modified by the extent of IHD burden (interaction p=0.99).
CONCLUSION: The angiographical presence of coronary collaterals is a clinical predictor of cardiovascular prognosis. Collaterals exert a protective effect on outcome in a broad spectrum of patients. Our data suggest that this protective effect is independent of disease burden, and remains present in patients with extensive IHD.

Entities:  

Mesh:

Year:  2008        PMID: 18242732     DOI: 10.1016/j.ijcard.2007.11.100

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  21 in total

1.  Association between circulating fibrocytes and angiographic coronary collaterals in patients with obstructive coronary artery disease.

Authors:  Mary C Shields; Borna Mehrad; Ellen C Keeley
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.

Authors:  Samim Emet; Ali Elitok; Imran Onur; Mehmet Kocaaga; Ahmet Kaya Bilge; Huseyin Oflaz; Berrin Umman; Aytac Oncul; Zehra Bugra; Kamil Adalet; Fehmi Mercanoglu
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

3.  Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial.

Authors:  Ph Gabriel Steg; Arthur Kerner; G B John Mancini; Harmony R Reynolds; Antonio C Carvalho; Viliam Fridrich; Harvey D White; Sandra A Forman; Gervasio A Lamas; Judith S Hochman; Christopher E Buller
Journal:  Circulation       Date:  2010-06-14       Impact factor: 29.690

4.  Effect of collaterals on deaths and re-infarctions in patients with coronary artery disease: a meta-analysis.

Authors:  S Akin; T Yetgin; J J Brugts; A Dirkali; F Zijlstra; T J Cleophas
Journal:  Neth Heart J       Date:  2013-03       Impact factor: 2.380

5.  Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion.

Authors:  Zhen Sun; Ying Shen; Lin Lu; Rui-yan Zhang; Li-jin Pu; Qi Zhang; Zheng-kun Yang; Jian Hu; Qiu-jing Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

Review 6.  Cardioprotection during ischemia by coronary collateral growth.

Authors:  Anurag Jamaiyar; Cody Juguilon; Feng Dong; Devan Cumpston; Molly Enrick; William M Chilian; Liya Yin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-31       Impact factor: 4.733

7.  Prediction for Coronary Collateral Development.

Authors:  Wei-Tsung Wu; Tsung-Hsien Lin; Po-Chao Hsu; Wen-Ter Lai; Sheng-Hsiung Sheu
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

8.  Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease.

Authors:  Po-Chao Hsu; Suh-Hang Juo; Ho-Ming Su; Szu-Chia Chen; Wei-chung Tsai; Wen-Ter Lai; Sheng-Hsiung Sheu; Tsung-Hsien Lin
Journal:  BMC Nephrol       Date:  2012-08-30       Impact factor: 2.388

9.  Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease.

Authors:  Ellen C Keeley; J Randall Moorman; Ling Liu; Lawrence W Gimple; Lewis C Lipson; Michael Ragosta; Angela M Taylor; Douglas E Lake; Marie D Burdick; Borna Mehrad; Robert M Strieter
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

10.  Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease.

Authors:  Po-Chao Hsu; Ho-Ming Su; Suh-Hang Juo; Hsueh-Wei Yen; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu; Tsung-Hsien Lin
Journal:  BMC Res Notes       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.